ANATOMY 37 LIMITED
Executive Summary
Anatomy 37 Limited demonstrates a stable financial position with positive net assets growth and ample liquidity, supported by up-to-date statutory compliance. Key risks to monitor include the director loan balance and intangible goodwill that could affect asset quality. Overall, the company currently presents a low risk profile for investors based on the available financial and compliance information.
View Full Analysis Report →- Legal registered address
- 36 Deacon Trading Estate Morley Road Tonbridge Kent United Kingdom TN9 1RA Copied!
Latest financial results as of 4 August 2025- Cash in bank
- £70.77k
- Current assets
- £123.43k
- Fixed assets
- £50.72k
- Current creditors
- £62.46k
- Shareholders funds
- £111.18k
View full financial accounts- Cash in bank
- £70.77k
- Current assets
- £123.43k
- Fixed assets
- £50.72k
- Current creditors
- £62.46k
- Shareholders funds
- £111.18k
- Company number
- 13622361 Copied!
Accounts
Latest annual accounts were to 30 September 2024
Next annual accounts are due by 30 June 2026
Company financial year end is on 30 September 2025
Confirmation statement
Latest confirmation statement statement dated 14 September 2024
Next statement due by 28 September 2025
Nature of business (SIC)
93110 - Operation of sports facilities
Latest company documents
| Date | Description |
|---|---|
| 02/04/252 April 2025 | Change of details for Mr Adam James Anthony Wilson as a person with significant control on 2025-03-20 |
| 02/04/252 April 2025 | Director's details changed for Mr Adam James Anthony Wilson on 2025-03-20 |
| 31/03/2531 March 2025 | Total exemption full accounts made up to 2024-09-30 |
| 30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
| 29/05/2429 May 2024 | Sub-division of shares on 2024-04-30 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company